TBCRC 008: Early Change in <sup>18</sup>F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast CancerRoisín M. Connolly, Vered Stearns, Xian Zhou et al.|Journal of Nuclear Medicine|2014Cited by 65
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast CancerRoisín M. Connolly, Vered Stearns, Jeffrey P. Leal et al.|Journal of Clinical Oncology|2021Cited by 46